Your browser doesn't support javascript.
loading
Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy Volunteers.
Weiser, Thomas; Schepers, Cornelia; Mück, Tobias; Lange, Robert.
Afiliação
  • Weiser T; Consumer Health Care, Medical Affairs, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
  • Schepers C; Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Frankfurt am Main, Germany.
  • Mück T; Consumer Health Care, Medical Affairs, Germany, Switzerland, Austria, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
  • Lange R; Consumer Health Care, Global Medical Affairs, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany.
Clin Pharmacol Drug Dev ; 8(6): 742-753, 2019 08.
Article em En | MEDLINE | ID: mdl-30897305
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cafeína / Ibuprofeno / Lisina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cafeína / Ibuprofeno / Lisina Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Drug Dev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha